Katherine E. Chapman

437 total citations
18 papers, 333 citations indexed

About

Katherine E. Chapman is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis and Small Animals. According to data from OpenAlex, Katherine E. Chapman has authored 18 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 8 papers in Health, Toxicology and Mutagenesis and 5 papers in Small Animals. Recurrent topics in Katherine E. Chapman's work include Carcinogens and Genotoxicity Assessment (13 papers), Effects and risks of endocrine disrupting chemicals (6 papers) and Animal testing and alternatives (5 papers). Katherine E. Chapman is often cited by papers focused on Carcinogens and Genotoxicity Assessment (13 papers), Effects and risks of endocrine disrupting chemicals (6 papers) and Animal testing and alternatives (5 papers). Katherine E. Chapman collaborates with scholars based in United Kingdom, United States and India. Katherine E. Chapman's co-authors include Shareen H. Doak, Gareth Jenkins, Ume-Kulsoom Shah, Neenu Singh, John W. Wills, Adam D. Thomas, Edwin I. Hatch, Edward S. Baum, Charlene P. Holton and Blaise E. Favara and has published in prestigious journals such as Cancer, Toxicological Sciences and Archives of Toxicology.

In The Last Decade

Katherine E. Chapman

16 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine E. Chapman United Kingdom 9 114 85 83 82 56 18 333
Jee Young Kwon South Korea 12 132 1.2× 56 0.7× 100 1.2× 140 1.7× 14 0.3× 20 507
Yuzuki Nakagawa Japan 8 93 0.8× 24 0.3× 79 1.0× 114 1.4× 23 0.4× 15 323
Stephen J. Evans United Kingdom 12 70 0.6× 143 1.7× 66 0.8× 78 1.0× 27 0.5× 25 414
Hisayo Kubota Japan 14 45 0.4× 25 0.3× 176 2.1× 118 1.4× 11 0.2× 25 457
Wenbo Bu China 12 55 0.5× 19 0.2× 76 0.9× 111 1.4× 9 0.2× 47 357
Buhyun Lee South Korea 9 25 0.2× 153 1.8× 23 0.3× 87 1.1× 10 0.2× 13 351
Ya-Ling Yeh Taiwan 13 63 0.6× 52 0.6× 22 0.3× 289 3.5× 3 0.1× 13 461
Marina González Argentina 10 68 0.6× 37 0.4× 22 0.3× 106 1.3× 4 0.1× 29 345
Shirin Hafezi United Arab Emirates 11 81 0.7× 18 0.2× 62 0.7× 164 2.0× 4 0.1× 25 437
Somnath Bandyopadhyay United States 10 29 0.3× 51 0.6× 47 0.6× 147 1.8× 3 0.1× 16 412

Countries citing papers authored by Katherine E. Chapman

Since Specialization
Citations

This map shows the geographic impact of Katherine E. Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Chapman more than expected).

Fields of papers citing papers by Katherine E. Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine E. Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Chapman. The network helps show where Katherine E. Chapman may publish in the future.

Co-authorship network of co-authors of Katherine E. Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine E. Chapman. A scholar is included among the top collaborators of Katherine E. Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine E. Chapman. Katherine E. Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
3.
4.
Llewellyn, Samantha V., Wolfgang J. Parak, Jonas Hühn, et al.. (2022). Deducing the cellular mechanisms associated with the potential genotoxic impact of gold and silver engineered nanoparticles upon different lung epithelial cell lines in vitro. Nanotoxicology. 16(1). 52–72. 5 indexed citations
5.
Chapman, Katherine E., Fiona Chapman, Ume-Kulsoom Shah, et al.. (2020). Multiple-endpoint in vitro carcinogenicity test in human cell line TK6 distinguishes carcinogens from non-carcinogens and highlights mechanisms of action. Archives of Toxicology. 95(1). 321–336. 8 indexed citations
6.
Chapman, Fiona, Chris Sparham, David J. Sanders, et al.. (2020). Comparison of passive-dosed and solvent spiked exposures of pro-carcinogen, benzo[a]pyrene, to human lymphoblastoid cell line, MCL-5. Toxicology in Vitro. 67. 104905–104905. 10 indexed citations
7.
Shah, Ume-Kulsoom, et al.. (2020). The effect of chronic dosing and p53 status on the genotoxicity of pro-oxidant chemicals in vitro. Mutagenesis. 35(6). 479–489. 1 indexed citations
8.
Shah, Ume-Kulsoom, Katherine E. Chapman, M. Rowan Brown, et al.. (2020). Detection of urethane-induced genotoxicity in vitro using metabolically competent human 2D and 3D spheroid culture models. Mutagenesis. 35(6). 445–452. 6 indexed citations
10.
Shah, Ume-Kulsoom, et al.. (2018). Reprint of: A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 834. 35–41. 11 indexed citations
11.
Chapman, Katherine E., George Hoffmann, Shareen H. Doak, & Gareth Jenkins. (2017). Investigation of J-shaped dose-responses induced by exposure to the alkylating agent N -methyl- N -nitrosourea. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 819. 38–46. 5 indexed citations
12.
Chapman, Katherine E., Anna L. Seager, Ume-Kulsoom Shah, et al.. (2017). A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells. Archives of Toxicology. 92(2). 935–951. 29 indexed citations
13.
Shah, Ume-Kulsoom, et al.. (2017). A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 825. 51–58. 77 indexed citations
14.
Chapman, Katherine E., Shareen H. Doak, & Gareth Jenkins. (2015). Acute Dosing and p53-Deficiency Promote Cellular Sensitivity to DNA Methylating Agents. Toxicological Sciences. 144(2). 357–365. 7 indexed citations
15.
Wills, John W., Nicole Hondow, Adam D. Thomas, et al.. (2015). Genetic toxicity assessment of engineered nanoparticles using a 3D in vitro skin model (EpiDerm™). Particle and Fibre Toxicology. 13(1). 50–50. 54 indexed citations
16.
Seager, Anna L., Ume-Kulsoom Shah, John W. Wills, et al.. (2014). Recommendations, evaluation and validation of a semi-automated, fluorescent-based scoring protocol for micronucleus testing in human cells. Mutagenesis. 29(3). 155–164. 29 indexed citations
17.
Chapman, Katherine E., Adam D. Thomas, John W. Wills, et al.. (2014). Automation and validation of micronucleus detection in the 3D EpiDerm™ human reconstructed skin assay and correlation with 2D dose responses. Mutagenesis. 29(3). 165–175. 30 indexed citations
18.
Holton, Charlene P., et al.. (1973). Extended combination therapy of childhood rhabdomyosarcoma. Cancer. 32(6). 1310–1316. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026